Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page